TXN and neoplasm: The effect of TrxR inhibition on tumor cell survival and aggressiveness is robust, and tumor proliferation appears to be dependent on an active Trx system, making TrxR a potential target for cancer chemotherapy [108,109,110,111,112] (Figure 3).